Uterine artery pulsatility index improves prediction of methotrexate resistance in women with gestational trophoblastic neoplasia with FIGO score 5-6.
BJOG
; 120(8): 1012-5, 2013 Jul.
Article
en En
| MEDLINE
| ID: mdl-23759086
ABSTRACT
OBJECTIVE:
The Uterine Artery Pulsatility Index (UAPI) is an ultrasound measure of tumour vascularity. In this study, we hypothesised that a UAPI ≤ 1 (high vascularity) would identify women with gestational trophoblastic neoplasia (GTN) at increased risk of resistance to first-line single-agent methotrexate (MTX-R).DESIGN:
Single-centre cohort study.SETTING:
Charing Cross Hospital, a UK national centre for the treatment of trophoblastic disease. POPULATION All women with a GTN FIGO score 5-6 treated with methotrexate (n = 92), between 1999 and 2011, at Charing Cross Hospital.METHODS:
UAPI was measured before the start of chemotherapy, and women were monitored for the development of MTX-R. MAIN OUTCOMEMEASURES:
Frequency of MTX-R in women with UAPI ≤ 1 compared with UAPI >1.RESULTS:
UAPI was measured before chemotherapy in 73 of 92 women with GTN FIGO score 5-6. UAPI ≤ 1 predicted MTX-R independent of the FIGO score (hazard ratio 2.9, P = 0.04), with an absolute risk of MTX-R in women with a UAPI ≤ 1 of 67% (95% CI 53-79%) compared with 42% (95% CI 24-61%) with a UAPI >1 (P = 0.036).CONCLUSION:
Our results suggest UAPI is an independent predictor of MTX-R in women with FIGO 5-6 GTN.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Uterinas
/
Metotrexato
/
Resistencia a Antineoplásicos
/
Enfermedad Trofoblástica Gestacional
/
Arteria Uterina
Tipo de estudio:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Límite:
Female
/
Humans
/
Pregnancy
País/Región como asunto:
Europa
Idioma:
En
Año:
2013
Tipo del documento:
Article